# Statistics in Medicine

Statistics in Medicine > 29 > 1 > 86 - 96

Statistics in Medicine > 29 > 1 > 75 - 85

Statistics in Medicine > 29 > 1 > 33 - 45

*p*‐values from tests of point null hypotheses of no association. Van de Wiel and Kim take the innovative approach of testing the interval null hypotheses that the degree of association for a gene is less than some value of interest against the alternative that it is greater...

Statistics in Medicine > 29 > 1 > 14 - 32

Statistics in Medicine > 29 > 1 > 63 - 74

*a priori*selection of channels and time windows of interest for studying the differences between experimental conditions in the spatio‐temporal domain. In this work we put forward a new strategy designed for situations when there is not

*a priori*information about ‘when’ and ‘where’ these differences appear in the spatio‐temporal...

Statistics in Medicine > 29 > 1 > 130 - 141

Statistics in Medicine > 29 > 1 > 142 - 157

Statistics in Medicine > 29 > 1 > 108 - 115

Statistics in Medicine > 29 > 1 > 158 - 180

Statistics in Medicine > 29 > 1 > 97 - 107

Statistics in Medicine > 29 > 1 > 1 - 13

Statistics in Medicine > 29 > 1 > 46 - 62

Statistics in Medicine > 29 > 1 > 116 - 129

Statistics in Medicine > 29 > 2 > 236 - 247

Statistics in Medicine > 29 > 2 > 210 - 218

Statistics in Medicine > 29 > 2 > 284 - 295

Statistics in Medicine > 29 > 2 > 193 - 198

Statistics in Medicine > 29 > 2 > 199 - 209

Statistics in Medicine > 29 > 2 > 275 - 283

*J. Epidemiol. Biostat.*1999; 4:53–60). It is based on a bivariate extension of the compound Poisson frailty model in univariate survival analysis (

*Ann. Appl. Probab.*1992; 4:951–972)...